Dan Brennan
Stock Analyst at TD Cowen
(4.12)
# 486
Out of 5,131 analysts
130
Total ratings
50.51%
Success rate
14.68%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $53 → $43 | $36.51 | +17.78% | 4 | Feb 13, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $18 → $19 | $18.12 | +4.86% | 6 | Feb 13, 2026 | |
| RVTY Revvity | Maintains: Buy | $120 → $124 | $96.03 | +29.13% | 4 | Feb 3, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $696 → $683 | $504.82 | +35.30% | 15 | Jan 30, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $116.81 | +19.85% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $212.58 | +27.01% | 7 | Jan 7, 2026 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $9.20 | +30.43% | 4 | Jan 7, 2026 | |
| MDXH MDxHealth | Maintains: Buy | $5 → $7 | $3.40 | +105.88% | 2 | Nov 13, 2025 | |
| WAT Waters | Maintains: Hold | $345 → $390 | $323.37 | +20.60% | 4 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $74 → $90 | $103.24 | -12.82% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $8 → $9 | $4.49 | +100.45% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $162 | $125.81 | +28.77% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $72 | $104.85 | -31.33% | 3 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $11.39 | +5.36% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $16.04 | -6.48% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $20.62 | +55.19% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $90.15 | +22.02% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $2.96 | -15.54% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $51.95 | +42.44% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $206.23 | -15.14% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $161.35 | +54.94% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $49.01 | +4.06% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $11.45 | +389.08% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $176.42 | +209.49% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.71 | +777.19% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $93.00 | +149.46% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,360.95 | -35.34% | 3 | Oct 7, 2020 |
Bruker
Feb 13, 2026
Maintains: Hold
Price Target: $53 → $43
Current: $36.51
Upside: +17.78%
10x Genomics
Feb 13, 2026
Maintains: Hold
Price Target: $18 → $19
Current: $18.12
Upside: +4.86%
Revvity
Feb 3, 2026
Maintains: Buy
Price Target: $120 → $124
Current: $96.03
Upside: +29.13%
Thermo Fisher Scientific
Jan 30, 2026
Maintains: Buy
Price Target: $696 → $683
Current: $504.82
Upside: +35.30%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $116.81
Upside: +19.85%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $212.58
Upside: +27.01%
Avantor
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $9.20
Upside: +30.43%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.40
Upside: +105.88%
Waters
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $323.37
Upside: +20.60%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $103.24
Upside: -12.82%
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $4.49
Upside: +100.45%
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $125.81
Upside: +28.77%
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $104.85
Upside: -31.33%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $11.39
Upside: +5.36%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $16.04
Upside: -6.48%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $20.62
Upside: +55.19%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $90.15
Upside: +22.02%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.96
Upside: -15.54%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $51.95
Upside: +42.44%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $206.23
Upside: -15.14%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $161.35
Upside: +54.94%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $49.01
Upside: +4.06%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $11.45
Upside: +389.08%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $176.42
Upside: +209.49%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.71
Upside: +777.19%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $93.00
Upside: +149.46%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,360.95
Upside: -35.34%